Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07531069) titled 'Efficacy and Safety of Interferon-Gamma Monoclonal Antibody Combined With Dexamethasone in the Treatment of Refractory Adult Secondary Hemophagocytic Lymphohistiocytosis' on April 2.

Study Type: Observational [Patient Registry]

Primary Sponsor: Fudan University

Condition: Adult Refractory Secondary Hemophagocytic Lymphohistiocytosis Secondary Hemophagocytic Lymphohistiocytosis HLH

Recruitment Status: Not recruiting

Date of First Enrollment: May 21, 2024

Target Sample Size: 22

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07531069

Published by HT Digital Content Se...